Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | GAA | P10253 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24171458 | 0.87 | SCN10A (0.32) | SCN10A | |
| SCHEMBL26999655 | 0.87 | SCN10A (0.48) | SCN10AALDH1A1GAAHPGDHSD17B10 | |
| SCHEMBL21104304 | 0.79 | — | — | |
| SCHEMBL11659128 | 0.79 | — | — | |
| SCHEMBL19523306 | 0.79 | — | — | |
| SCHEMBL30462995 | 0.79 | KIF11 (0.37) | — | |
| Hydrochloric Acid SCHEMBL3932764 | 0.78 | ADRB2 (0.34) | SCN10A | |
| SCHEMBL21221633 | 0.76 | — | — | |
| SCHEMBL5014500 | 0.75 | — | — | |
| SCHEMBL23680086 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11168239-B2 | Chemical-mechanical polishing composition comprising benzotriazole derivatives as corrosion inhibitors | BASF SE | 2021-11-09 | — | — | US | claimed |
| US-10647900-B2 | Chemical-mechanical polishing composition comprising benzotriazole derivatives as corrosion inhibitors | BASF SE (DE) | 2020-05-12 | — | — | US | claimed |
| EP-3019569-B1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION COMPRISING BENZOTRIAZOLE DERIVATIVES AS CORROSION INHIBITORS | BASF SE (DE) | 2018-05-30 | — | — | EP | claimed |
| US-20160200943-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION COMPRISING BENZOTRIAZOLE DERIVATIVES AS CORROSION INHIBITORS | BASF SE (DE) | 2016-07-14 | — | — | US | claimed |
| EP-3019569-A2 | CHEMICAL-MECHANICAL POLISHING COMPOSITION COMPRISING BENZOTRIAZOLE DERIVATIVES AS CORROSION INHIBITORS | BASF SE (DE) | 2016-05-18 | — | — | EP | claimed |
| CN-105378011-A | Chemical-mechanical polishing composition comprising benzotriazole derivatives as corrosion inhibitors | BASF SE | 2016-03-02 | — | — | CN | claimed |
| US-12351737-B2 | Chemical mechanical polishing of substrates containing copper and ruthenium | BASF SE (DE) | 2025-07-08 | — | — | US | disclosed |
| US-20240002698-A1 | CHEMICAL MECHANICAL POLISHING OF SUBSTRATES CONTAINING COPPER AND RUTHENIUM | BASF SE (DE) | 2024-01-04 | — | — | US | disclosed |
| US-20230416570-A1 | CHEMICAL MECHANICAL POLISHING OF SUBSTRATES CONTAINING COPPER AND RUTHENIUM | BASF SE (DE) | 2023-12-28 | — | — | US | disclosed |
| US-11725117-B2 | Chemical mechanical polishing of substrates containing copper and ruthenium | BASF SE (DE) | 2023-08-15 | — | — | US | disclosed |
| US-20230123569-A1 | COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | LIGACHEM BIOSCIENCES INC. (KR) | 2023-04-20 | — | — | US | disclosed |
| US-20220064485-A1 | CHEMICAL MECHANICAL POLISHING OF SUBSTRATES CONTAINING COPPER AND RUTHENIUM | BASF SE (DE) | 2022-03-03 | — | — | US | disclosed |
| US-20220056307-A1 | CHEMICAL MECHANICAL POLISHING OF SUBSTRATES CONTAINING COPPER AND RUTHENIUM | BASF SE (DE) | 2022-02-24 | — | — | US | disclosed |
| EP-3019569-B1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION COMPRISING BENZOTRIAZOLE DERIVATIVES AS CORROSION INHIBITORS | BASF SE (DE) | 2018-05-30 | — | — | EP | disclosed |
| US-20160200943-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION COMPRISING BENZOTRIAZOLE DERIVATIVES AS CORROSION INHIBITORS | BASF SE (DE) | 2016-07-14 | — | — | US | disclosed |
| EP-3019569-A2 | CHEMICAL-MECHANICAL POLISHING COMPOSITION COMPRISING BENZOTRIAZOLE DERIVATIVES AS CORROSION INHIBITORS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| CN-105378011-A | Chemical-mechanical polishing composition comprising benzotriazole derivatives as corrosion inhibitors | BASF SE | 2016-03-02 | — | — | CN | disclosed |
| EP-1830846-A4 | THIAZOLIUM COMPOUNDS AND USES THEREOF | MYCOSOL INC (US) | 2008-07-02 | — | — | EP | disclosed |
| EP-1830846-A2 | THIAZOLIUM COMPOUNDS AND USES THEREOF | Mycosol, Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006065942-A2 | THIAZOLIUM COMPOUNDS AND USES THEREOF | MYCOSOL, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230123569-A1 | COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | ENPP2, PLA2G10, LPCAT1 | SCN10A 2309/4885ALDH1A1 4207/4885GAA 1678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.